US Edition
News from Express Pharma
Media Bias Ratings
Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top Express Pharma News
AbbVieAbbVie has acquired rights to a multispecific antibody that IGI Therapeutics designed to bind to three targets to treat multiple myeloma. Early Phase 1 results showed encouraging responses in a heavily pretreated patient population and a favorable safety profile.See the Story
AbbVie Pays $700M for Drug Engineered to Overcome Resistance in Multiple Myeloma
57% Center coverage: 7 sources
HIVAurobindo Pharma will manufacture and supply the long-acting injectable HIV treatment cabotegravir across 133 countries. As part of an expanded licensing agreement with the Medicines Patent Pool and ViiV Healthcare, this initiative will extend access to low and middle-income markets, promoting advanced HIV treatment alternatives.See the Story
Aurobindo Pharma Leads Charge in Global HIV Treatment Expansion
50% Center coverage: 6 sources
LifestylePennington Biomedical researchers and their collaborators observed decreased activity in the brain regions responsible for hunger and reward in patients treated with tirzepatide. A recent study has shown that tirzepatide, a medication commonly prescribed for type 2 diabetes and weight management, led to greater reductions in body weight, food consumption, and various appetite-related measures when [...]See the Story
This Obesity Drug Cuts Calorie Intake by 72% Without Dieting
Coverage: 2 sources
